DGX (Quest Diagnostics Inc.) Enterprise Value-to-Revenue Coefficient

Public company logo of questdiagnostics.com (DGX)

Quest Diagnostics is facing a decline in demand for PCR tests and a reduction in government payments, as illustrated by the EV/Sales multiple chart, where the 2904.47 level captures current values. The company is tackling medical waste by optimizing the transport of biomaterials. Additionally, plastic recycling systems and center energy-saving measures are being implemented to comply with environmental regulations.

questdiagnostics.com - DGX EV/Sales Multiple (period 11/23/2025 - 11/20/2026)

Quest Diagnostics Inc. - analytical breakdowns and key metrics (DGX)

Fundamental company valuation:DGX questdiagnostics.com
Original product of Quest Diagnostics Incorporated

A conservative approach requires valuing the business inclusive of net debt to eliminate the impact of leverage. This indicator compares the total enterprise value to annual revenue, identifying whether the asset is overbought or undervalued. By analyzing the enterprise value-to-revenue trend, an investor can see the resilience of Quest Diagnostics (DGX), where a steady stream of test orders confirms the fundamental reliability and operational efficiency of the model.

Competitor analysis

A (Agilent) - Company Value to Revenue Ratio|ILMN (illumina.com) - Company Value to Revenue|Company Value to Revenue Cologuard|RVTY (Revvity Corp) - EV/Sales Multiple|EV/Sales Multiple Bio-Rad Laboratories Inc|Company Value to Revenue NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio QuidelOrtho Inc. QDEL|EV/Sales Multiple OPKO Health Inc OPK|CareDx Inc - EV/Sales Multiple|Business Value to Revenue MRVI (Maravai)|FLGT: EV/Sales Multiple|LAB (Standard BioTools Inc.) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Cytek Biosciences Inc|Enterprise Value-to-Revenue Multiple OraSure OSUR|Company Value to Revenue XGN (Exagen Diagnostics)|Total Company Value-to-Revenue Ratio MDxHealth Inc.|Enterprise Value-to-Revenue Ratio Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Enterprise Value-to-Revenue Multiple|Insight Molecular Diagnostics Inc - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple trinitybiotech.com|PRPH (ProPhase) - Company Value to Revenue|Company Value to Revenue Ratio AIMD|Company Value to Revenue CODX|Enterprise Value-to-Revenue Multiple heartsciences.com HSCS|Enterprise Value-to-Revenue Ratio Biomerica Inc. (BMRA)|Total Company Value-to-Revenue Ratio Cardio Diagnostics Holdings|EV/Sales Multiple ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Enterprise Value-to-Revenue Multiple|bluejaydx.com - EV/Sales Multiple|Aspira Women's Health - Enterprise Value-to-Revenue Coefficient|AXDX (Accelerate Diagnostics) - Company Value to Revenue|Company Value to Revenue CENTOGENE, N.V.|Enterprise Value-to-Revenue Ratio enzo.com|EV/Sales Multiple Fresh2 Group Limited|EV/Sales Multiple GENE|23andMe Holding Co. - Company Value to Revenue Ratio|Psychemedics Inc - Company Value to Revenue